Skip to main content
Premium Trial:

Request an Annual Quote

Tripos to Acquire Optive Research for $8M in Stock, Cash

NEW YORK, Dec. 22 (GenomeWeb News) - Tripos plans to acquire Optive Research, a discovery informatics software developer, for approximately $8 million in stock and cash, the St. Louis-based company said today.


Under the agreement, Optive shareholders will receive 599,521 shares of Tripos common stock, worth about $3.2 million at the end of trading yesterday, and $4.75 million in cash. A new group of investors will fund the cash portion of the deal through $3.5 million of subordinated debt, 111,606 shares of common stock, and warrants to purchase 156,250 shares of common stock.


The acquisition is expected to close in January. Tripos expects Optive to contribute to its operating income in 2005, and to net income beginning in 2006.


Tripos already distributes five or more than 15 software products from Optive, a 2002 spinout from the University of Texas at Austin.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.